LETROZOLE\RIBOCICLIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 16 adverse event reports in the FDA FAERS database where LETROZOLE\RIBOCICLIB was used for Neoplasm malignant.
Most Reported Side Effects for LETROZOLE\RIBOCICLIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 69 | 11.1% | 3 | 11 |
| Death | 66 | 10.6% | 66 | 0 |
| Nausea | 57 | 9.2% | 3 | 3 |
| White blood cell count decreased | 39 | 6.3% | 2 | 6 |
| Diarrhoea | 35 | 5.6% | 0 | 6 |
| Rash | 27 | 4.4% | 1 | 0 |
| Alopecia | 25 | 4.0% | 0 | 3 |
| Neoplasm malignant | 25 | 4.0% | 1 | 3 |
| Malaise | 24 | 3.9% | 0 | 1 |
| Cough | 22 | 3.5% | 0 | 3 |
| Disease progression | 22 | 3.5% | 1 | 1 |
| Product dose omission issue | 22 | 3.5% | 0 | 5 |
| Vomiting | 22 | 3.5% | 0 | 3 |
| Headache | 21 | 3.4% | 0 | 2 |
| Drug ineffective | 20 | 3.2% | 0 | 1 |
Other Indications for LETROZOLE\RIBOCICLIB
Product used for unknown indication (327)
Breast cancer (114)
Breast cancer female (47)
Breast cancer metastatic (44)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)